PRME (Prime Medicine) Institutional Ownership: 59.15% (As of Jul. 02, 2026)


PRME Prime Medicine Inc PRME
28 GF Score
Price $3.89
! 5 Warning Signs
View Full Analysis

What is Prime Medicine Institutional Ownership?

Prime Medicine PRME +0.13% 28 Institutional Ownership is 59.15% as of Jul. 02, 2026. GuruFocus rates PRME with a GF Score™ of 28/100. The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Prime Medicine's institutional ownership is 59.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Prime Medicine's Insider Ownership is 2.05%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Prime Medicine's Float Percentage Of Total Shares Outstanding is 78.13%.

Prime Medicine Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Prime Medicine's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prime Medicine Institutional Ownership Chart

Prime Medicine Historical Data

The historical data trend for Prime Medicine can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 23.95 24.26 24.04 27.34 27.53 27.73 27.47 27.41 27.06 27.72
PRME
28GF Score
Prime Medicine Inc PRME
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prime Medicine Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 59.15% mean?
Prime Medicine (PRME) has a Institutional Ownership of 59.15% as of Jul. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Prime Medicine and its competitors.
Is Prime Medicine's Institutional Ownership too high?
Prime Medicine's current Institutional Ownership is 59.15%. Overall, Prime Medicine has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Prime Medicine's Institutional Ownership compare to EIKN and CRMD?
Prime Medicine's Institutional Ownership of 59.15% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Prime Medicine and its competitors. Prime Medicine's current Institutional Ownership is 59.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prime Medicine stock overvalued right now?
Prime Medicine (PRME) has a current Institutional Ownership of 59.15%. The current Institutional Ownership is 59.15%. Prime Medicine's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Prime Medicine (PRME), the current Institutional Ownership is 59.15% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prime Medicine Business Description

Address 60 First Street, Cambridge, MA, USA, 02141
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
28GF Score

Get the complete analysis for PRME

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.89
Price